Allergy Therapeutics (AGY) Competitors GBX 5.20 -0.30 (-5.45%) (As of 11:52 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines AGY vs. AMYT, APH, BXP, ANCR, DNL, EAH, STX, CHLL, PXS, and MXCShould you be buying Allergy Therapeutics stock or one of its competitors? The main competitors of Allergy Therapeutics include Amryt Pharma (AMYT), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Chill Brands Group (CHLL), Provexis (PXS), and Argent BioPharma (MXC). These companies are all part of the "drug manufacturers - specialty & generic" industry. Allergy Therapeutics vs. Amryt Pharma Alliance Pharma Beximco Pharmaceuticals Animalcare Group Diurnal Group ECO Animal Health Group Shield Therapeutics Chill Brands Group Provexis Argent BioPharma Amryt Pharma (LON:AMYT) and Allergy Therapeutics (LON:AGY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Does the media prefer AMYT or AGY? In the previous week, Allergy Therapeutics' average media sentiment score of 0.67 beat Amryt Pharma's score of 0.00 indicating that Allergy Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Amryt Pharma Neutral Allergy Therapeutics Positive Does the MarketBeat Community prefer AMYT or AGY? Allergy Therapeutics received 118 more outperform votes than Amryt Pharma when rated by MarketBeat users. Likewise, 77.97% of users gave Allergy Therapeutics an outperform vote while only 65.68% of users gave Amryt Pharma an outperform vote. CompanyUnderperformOutperformAmryt PharmaOutperform Votes24365.68% Underperform Votes12734.32% Allergy TherapeuticsOutperform Votes36177.97% Underperform Votes10222.03% Which has stronger valuation & earnings, AMYT or AGY? Amryt Pharma has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Amryt Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmryt Pharma£210.24M2.17N/A-£33.00-4.33Allergy Therapeutics£53.26M4.57-£50.22M-£0.06-85.00 Is AMYT or AGY more profitable? Amryt Pharma has a net margin of 0.00% compared to Allergy Therapeutics' net margin of -94.29%. Amryt Pharma's return on equity of 0.00% beat Allergy Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Amryt PharmaN/A N/A N/A Allergy Therapeutics -94.29%-155.90%-34.76% SummaryAmryt Pharma and Allergy Therapeutics tied by winning 5 of the 10 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGY vs. The Competition Export to ExcelMetricAllergy TherapeuticsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£243.27M£1.17B£5.05B£1.38BDividend Yield8.33%3.13%4.97%11.73%P/E Ratio-85.00110.0297.341,551.35Price / Sales4.572,171.601,218.42209,189.85Price / Cash3.6610.4333.5132.93Price / Book5.103.135.802.80Net Income-£50.22M£159.31M£119.07M£152.70M7 Day Performance-7.27%-1.08%-1.83%-0.54%1 Month Performance2.00%-3.82%-3.64%7.07%1 Year Performance200.00%87.63%31.62%91.74% Allergy Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGYAllergy TherapeuticsN/AGBX 5.20-5.5%N/A+205.6%£248.04M£53.26M-86.67612Gap DownAMYTAmryt PharmaN/AGBX 143-11.7%N/A+0.0%£457.11M£210.24M-4.33290Gap DownAPHAlliance Pharma2.5903 of 5 starsGBX 44.50+0.5%GBX 60+34.8%+16.6%£240.55M£183.15M-745.8391,000BXPBeximco PharmaceuticalsN/AGBX 34+4.6%N/A-24.4%£151.68M£43.08B425.005,500Gap UpANCRAnimalcare GroupN/AGBX 244-2.0%N/A+41.6%£147.30M£76.10M3,086.25220News CoverageDNLDiurnal GroupN/AGBX 27.30flatN/A+0.0%£46.33M£4.68M-3.2133EAHECO Animal Health GroupN/AGBX 63.77-3.4%N/A-41.3%£43.20M£89.42M3,300.00234Gap DownSTXShield TherapeuticsN/AGBX 2.95+10.3%N/A-56.1%£23.07M£21.47M-72.5040,000News CoverageGap UpHigh Trading VolumeCHLLChill Brands GroupN/AGBX 2.15flatN/AN/A£10.89M£624,187.00-215.007PXSProvexisN/AGBX 0.46-12.4%N/A-8.2%£10.37M£426,168.0043.754Gap DownMXCArgent BioPharmaN/AGBX 22+4.8%N/A-43.6%£9.65M£1.32M-13.255Gap Up Related Companies and Tools Related Companies AMYT Competitors APH Competitors BXP Competitors ANCR Competitors DNL Competitors EAH Competitors STX Competitors CHLL Competitors PXS Competitors MXC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:AGY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGY Stock Alerts